Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Telmisartan products are in shortage in Canada (3 of 26 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An angiotensin receptor blocker used to lower high blood pressure.
Products affected
3 / 26
In shortage since
Nov 21, 2024
Reports on file
123
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-TELMISARTAN
80MG · TABLET · TEVA CANADA LIMITED
DIN 02320185 · since Dec 3, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-TELMISARTAN
40MG · TABLET · TEVA CANADA LIMITED
DIN 02320177 · since Jan 7, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
BIO-TELMISARTAN
80MG · TABLET · BIOMED PHARMA
DIN 02522926 · since Nov 21, 2024, no end estimate · Décision de la compagnie:
Produit sera mis dormant
Resolved
ACH-TELMISARTAN
40MG · TABLET · ACCORD HEALTHCARE INC
DIN 02407485 · ended Dec 19, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
JAMP TELMISARTAN
80MG · TABLET · JAMP PHARMA CORPORATION
DIN 02386763 · ended Oct 31, 2025 · Demand increase for the drug.
Resolved
TELMISARTAN
80MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02390353 · ended Jul 31, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ TELMISARTAN
80MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02375966 · ended Jul 14, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ TELMISARTAN
40MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02375958 · ended Mar 24, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
JAMP TELMISARTAN
40MG · TABLET · JAMP PHARMA CORPORATION
DIN 02386755 · ended Mar 17, 2025 · Disruption of the manufacture of the drug.
Avoided
SANDOZ TELMISARTAN
40MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02375958 · ended Jan 13, 2024 · Delay in shipping of the drug.
Resolved
SANDOZ TELMISARTAN
40MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02375958 · ended Dec 23, 2024 · Disruption of the manufacture of the drug.
Resolved
JAMP TELMISARTAN
80MG · TABLET · JAMP PHARMA CORPORATION
DIN 02386763 · ended Dec 9, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Telmisartan is currently affected by 3 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, BIOMED PHARMA.
The reported causes are: disruption of the manufacture of the drug; décision de la compagnie:
produit sera mis dormant. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Telmisartan is classified under “ANGIOTENSIN II ANTAGONISTS, PLAIN” (ATC C09CA).
Recent changes
No changes recorded yet.
Common questions
What is Telmisartan used for?
An angiotensin receptor blocker used to lower high blood pressure.
When will Telmisartan be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Telmisartan in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.